Gene · 4303
Papers2,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating machine learning with mendelian randomization for unveiling causal gene networks in glioblastoma multiforme. | Discov Oncol | 2025 | 39804431 | PubTator, text mining | PubMed |
| The link of FOXO1 and FOXO4 transcription factors to development of the lens. | Dev Dyn | 2025 | 39797725 | PubTator, text mining | PubMed |
| Punicalagin inhibits excessive autophagy and improves cerebral function in neonatal rats with hypoxia-ischemia brain injury by regulating AKT-FOXO4. | Phytomedicine | 2025 | 39756314 | PubTator, text mining | PubMed |
| Helicobacter Pylori-induced BRD2 m6A modification sensitizes gastric cancer cells to chemotherapy by breaking FLIP/Caspase-8 homeostasis. | Int J Biol Sci | 2025 | 39744419 | PubTator, text mining | PubMed |
| Antiviral activity of HuaganJiedu decoction (HGJDD) against hepatitis B virus (HBV) through FOXO4/ERK/HNF4α signal pathway. | J Ethnopharmacol | 2025 | 39701219 | PubTator, text mining | PubMed |
| Immunocytochemistry-Based Detection of FOXO Isoforms in Human Cancer and Fibroblasts. | Methods Mol Biol | 2025 | 39565588 | PubTator, text mining | PubMed |
| FOXO Transcription Factors: A Brief Overview. | Methods Mol Biol | 2025 | 39565573 | PubTator, text mining | PubMed |
| FoxO1 signaling in B cell malignancies and its therapeutic targeting. | FEBS Lett | 2025 | 39533662 | PubTator, text mining | PubMed |
| FOXO4 suppresses cisplatin resistance of triple-negative breast cancer by inhibiting autophagy. | Am J Med Sci | 2025 | 39154963 | PubTator, text mining | PubMed |
| POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation. | Endocrine | 2025 | 39136897 | PubTator, text mining | PubMed |
| Unravelling the molecular mechanistic pathway underlying the anticancer effects of kaempferol in colorectal cancer: a reverse pharmacology network approach. | Mol Divers | 2025 | 38795259 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals the genetic basis underlying the formation and seasonal changes of nuptial pads in Rana chensinensis. | BMC Genomics | 2024 | 39736519 | PubTator, text mining | PubMed |
| Pseudokinase STK40 promotes TH1 and TH17 cell differentiation by targeting FOXO transcription factors. | Sci Adv | 2024 | 39565845 | PubTator, text mining | PubMed |
| Embracing the informative missingness and silent gene in analyzing biologically diverse samples. | Sci Rep | 2024 | 39550430 | PubTator, text mining | PubMed |
| NMR investigation of FOXO4-DNA interaction for discriminating target and non-target DNA sequences. | Commun Biol | 2024 | 39487330 | PubTator, text mining | PubMed |
| Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines. | Cancer Genomics Proteomics | 2024 | 39467632 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing. | J Tissue Eng | 2024 | 39371940 | PubTator, text mining | PubMed |
Correction to "FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway"Han XD, Yuan T, Zhang JL, et al. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway. J Cell Mol Med. 2022;26(11):3269-3280. | J Cell Mol Med | 2024 | 39166551 | PubTator, text mining | PubMed |
| Identification of a prognosis-related phagocytosis regulator gene signature in medulloblastoma. | Heliyon | 2024 | 39130452 | PubTator, text mining | PubMed |
| Retraction: Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling. | Front Cell Dev Biol | 2024 | 39100098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4303/papers?page=5